✦ LIBER ✦

TNM staging of renal cell carcinoma : Workgroup No. 3

✍ Scribed by Patrick Guinan; Leslie H. Sobin; Ferran Algaba; Fausto Badellino; Shuji Kameyama; Gregory MacLennan; Andrew Novick

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 49 KB
Volume: 80
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19970901)80:5<992::aid-cncr26>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Classification of renal cell carcinoma :

Classification of renal cell carcinoma : Workgroup No. 1

✍ Stephan Störkel; John N. Eble; K. Adlakha; Mahul Amin; Michael L. Blute; David G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

I n developing this proposal, the authors applied these principles: 1. The classification must be based on morphology yet be in line with the genetic facts as they are presently understood, and in line with the evolution of the neoplasms. 2. The terms should be simple, unambiguous, and reflect a sa

Grading of renal cell carcinoma : Workgr

Grading of renal cell carcinoma : Workgroup No. 2

✍ L. Jeffrey Medeiros; Edward C. Jones; Shigeo Aizawa; Hector C. Aldape; John C. C 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 1 views

and papillary renal cell carcinoma. The data supporting the validity of nuclear grading for chromophobe carcinoma is not well estab-Presented at ''Diagnosis and Prognosis of Renal lished, but it seems reasonable to grade these tumors for ongoing

Current prognostic factors-renal cell ca

Current prognostic factors-renal cell carcinoma : Workgroup No. 4

✍ John R. Srigley; Robert V. P. Hutter; Arnold B. Gelb; Donald E. Henson; Gerald K 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

Category III, the final category applies to those factors that show some promise but do not meet the above criteria.

Pathologic staging of renal cell carcino

Pathologic staging of renal cell carcinoma : Significance of tumor classification with the 1997 TNM staging system

✍ Matthew T. Gettman; Michael L. Blute; Bruce Spotts; Sandra C. Bryant; Horst Zinc 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Future prognostic factors for renal cell

Future prognostic factors for renal cell carcinoma : Workgroup No. 5

✍ David A. Swanson; Harold J. Rothenberg; Alton L. Boynton; David Consigliere; Kev 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

cause they may be impractical, expensive, or unproven. Group II is an intermediate group expected to be available in the near future and Presented at ''Diagnosis and Prognosis of Renal characterized by greater requirements for time, money, and other Cell Carcinoma: 1997 Workshop,'' Rochester, resour

Clinical research priorities in Renal ce

Clinical research priorities in Renal cell carcinoma : Renal cell carcinoma chemoprevention strategies including target populations, proposed agents, and clinical trial designs—Workgroup No. 6

✍ Kamal A. Hanash; Joseph W. Aquilina; David M. Barrett; Michael L. Blute; Abraham 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

C hemoprevention refers to the prevention of cancer or reduction of risk in susceptible individuals by the administration of natural or synthetic drugs with minimal toxicity to suppress, delay, or reverse carcinogenesis. 1 Chemoprevention is most effective in the early stages of cancer formation whe